Improving the diagnosis of severe malaria in African children using platelet counts and plasma Pf HRP2 concentrations
File(s)Defining_severe_malaria.pdf (2.55 MB)
Accepted version
Author(s)
Type
Journal Article
Abstract
Severe falciparum malaria is difficult to diagnose accurately in children in
high transmission settings. Using data from 2,649 patients enrolled in four
studies of severe illness in three countries (Bangladesh, Kenya, and Uganda),
we fitted Bayesian latent class models using two diagnostic biomarkers: the
platelet count and the plasma PfHRP2 concentration. In severely ill patients
with clinical features consistent with severe malaria, a combined platelet count
≤ 150,000 per µL and a plasma PfHRP2 concentration ≥ 1,000 ng/mL had an
estimated sensitivity of 74% and specificity of 93% in identifying ‘true’ severe
falciparum malaria. Compared to misdiagnosed children, patients with true
severe malaria had higher parasite densities, lower hematocrits, lower rates
of invasive bacterial disease, and a lower prevalence of both HbAS and HbSS.
We estimate one third of African children enrolled in clinical studies of severe
malaria in high transmission settings had another cause of severe illness.
high transmission settings. Using data from 2,649 patients enrolled in four
studies of severe illness in three countries (Bangladesh, Kenya, and Uganda),
we fitted Bayesian latent class models using two diagnostic biomarkers: the
platelet count and the plasma PfHRP2 concentration. In severely ill patients
with clinical features consistent with severe malaria, a combined platelet count
≤ 150,000 per µL and a plasma PfHRP2 concentration ≥ 1,000 ng/mL had an
estimated sensitivity of 74% and specificity of 93% in identifying ‘true’ severe
falciparum malaria. Compared to misdiagnosed children, patients with true
severe malaria had higher parasite densities, lower hematocrits, lower rates
of invasive bacterial disease, and a lower prevalence of both HbAS and HbSS.
We estimate one third of African children enrolled in clinical studies of severe
malaria in high transmission settings had another cause of severe illness.
Date Issued
2022-07-20
Date Acceptance
2022-03-09
Citation
Science Translational Medicine, 2022, 14 (654), pp.1-10
ISSN
1946-6234
Publisher
American Association for the Advancement of Science
Start Page
1
End Page
10
Journal / Book Title
Science Translational Medicine
Volume
14
Issue
654
Copyright Statement
© 2022 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works
Sponsor
Wellcome Trust
Wellcome Trust
Wellcome Trust
Wellcome Trust
Medical Research Council (MRC)
Wellcome Trust
Identifier
https://www.science.org/doi/10.1126/scitranslmed.abn5040
Grant Number
091758/B/10/Z
203077/Z/16/Z (C161)
202800/Z/16/Z
203077/C/16/Z
G0601027
209265/Z/17/Z
Subjects
Adult
Antigens, Protozoan
Bayes Theorem
Child
Humans
Malaria
Malaria, Falciparum
Plasmodium falciparum
Platelet Count
Protozoan Proteins
Uganda
Humans
Plasmodium falciparum
Malaria
Malaria, Falciparum
Protozoan Proteins
Antigens, Protozoan
Platelet Count
Bayes Theorem
Adult
Child
Uganda
06 Biological Sciences
11 Medical and Health Sciences
Publication Status
Published
Date Publish Online
2022-07-20